Dablo, Erwin .

HRN: 29-11-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CEFTRIAXONE 1G (VIAL)
06/08/2026
06/14/2026
IV
2gm
OD
Diabetic Foot, Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines